99 related articles for article (PubMed ID: 7016239)
1. The clinical course in patients with renal carcinoma subjected to extracorporeal immunoadsorption.
Wolf H; Langvad E; Hydén H
Br J Urol; 1981 Apr; 53(2):89-94. PubMed ID: 7016239
[TBL] [Abstract][Full Text] [Related]
2. A phase II trial of extracorporeal plasma immunoadsorption of patient plasma with PROSORBA columns for treating metastatic breast cancer.
Fennelly DW; Norton L; Sznol M; Hakes TB
Cancer; 1995 Apr; 75(8):2099-102. PubMed ID: 7697600
[TBL] [Abstract][Full Text] [Related]
3. Endogenous immune complex nephropathy associated with malignancy I. Studies on the nature and immunopathogenic significance of glomerular bound antigen and antibody, isolation and characterization of tumor specific antigen and antibody and circulating immune complexes.
Ozawa T; Pluss R; Lacher J; Boedecker E; Guggenheim S; Hammond W; McIntosh R
Q J Med; 1975 Oct; 44(176):523-41. PubMed ID: 53850
[TBL] [Abstract][Full Text] [Related]
4. Treatment of antibody-mediated rejection including immunoadsorption during first year after renal transplantation--Clinical results and regulation of endothelial progenitor cells.
Opgenoorth M; Wagner A; Passauer J; Hohenstein B; Hugo C
Atheroscler Suppl; 2015 May; 18():67-73. PubMed ID: 25936307
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of extracorporeal on-line large-scale plasma adsorptions on protein A-sepharose columns in cancer patients.
Wallmark A; Grubb A; Freiburghaus C; Flodgren P; Husberg B; Lindholm T; Lindström C; Thysell H; Sjögren HO
Artif Organs; 1984 Feb; 8(1):72-81. PubMed ID: 6367720
[TBL] [Abstract][Full Text] [Related]
6. Extracorporeal immunoadsorption for the treatment of coagulation inhibitors.
Franchini M; Sassi M; Dell'Anna P; Manzato F; Salvagno GL; Montagnana M; Zaffanello M; Targher G; Lippi G
Semin Thromb Hemost; 2009 Feb; 35(1):76-80. PubMed ID: 19308895
[TBL] [Abstract][Full Text] [Related]
7. Enzyme therapy and immuno-adsorption by an extra-corporeal device.
Hydén H
Biomater Med Devices Artif Organs; 1980; 8(1):1-11. PubMed ID: 6988019
[TBL] [Abstract][Full Text] [Related]
8. Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation.
Palmer A; Taube D; Welsh K; Bewick M; Gjorstrup P; Thick M
Lancet; 1989 Jan; 1(8628):10-2. PubMed ID: 2563001
[TBL] [Abstract][Full Text] [Related]
9. Preliminary characterization of a colon tumour tissue preparation used in macrophage electrophoretic mobility (MEM) test1.
Grossmann H; Müller M; Heidl G; Irmscher J; Kotzsch M; Wagner H
Arch Geschwulstforsch; 1981; 51(4):310-6. PubMed ID: 7032449
[TBL] [Abstract][Full Text] [Related]
10. Local anticoagulation of the extracorporeal circuit with heparin and subsequent neutralization with protamine during immunoadsorption.
Schmaldienst S; Goldammer A; Spitzauer S; Derfler K; Hörl WH; Knöbl P
Am J Kidney Dis; 2000 Sep; 36(3):490-7. PubMed ID: 10977780
[TBL] [Abstract][Full Text] [Related]
11. Extracorporeal removal of tumor antigens.
Shettigar UR; Kolff WJ; Gregonis D
ASAIO Trans; 1986; 32(1):583-6. PubMed ID: 3778776
[No Abstract] [Full Text] [Related]
12. Phase 1 trial of allogeneic gene-modified tumor cell vaccine RCC-26/CD80/IL-2 in patients with metastatic renal cell carcinoma.
Buchner A; Pohla H; Willimsky G; Frankenberger B; Frank R; Baur-Melnyk A; Siebels M; Stief CG; Hofstetter A; Kopp J; Pezzutto A; Blankenstein T; Oberneder R; Schendel DJ
Hum Gene Ther; 2010 Mar; 21(3):285-97. PubMed ID: 19788391
[TBL] [Abstract][Full Text] [Related]
13. Modification of hyperacute renal xenograft rejection after extracorporeal immunoadsorption of heterospecific antibody.
Terman DS; Garcia-Rinaldi R; McCalmon R; Crumb CC; Mattioli C; Cook G; Poser R
Int J Artif Organs; 1979 Jan; 2(1):35-41. PubMed ID: 387618
[No Abstract] [Full Text] [Related]
14. Background and indications for protein A-based extracorporeal immunoadsorption.
Matic G; Bosch T; Ramlow W
Ther Apher; 2001 Oct; 5(5):394-403. PubMed ID: 11778926
[TBL] [Abstract][Full Text] [Related]
15. Treatment of rapidly progressive glomerulonephritis by extracorporeal immunoadsorption, prednisolone and cyclophosphamide.
Palmer A; Cairns T; Dische F; Gluck G; Gjorstrup P; Parsons V; Welsh K; Taube D
Nephrol Dial Transplant; 1991; 6(8):536-42. PubMed ID: 1956551
[TBL] [Abstract][Full Text] [Related]
16. Extracorporeal immunoadsorption of myeloma IgG and autoimmune antibodies: a clinically feasible modality of treatment.
Ray PK; Besa E; Idiculla A; Rhoads JE; Bassett JG; Cooper DR
Clin Exp Immunol; 1980 Nov; 42(2):308-14. PubMed ID: 7008987
[TBL] [Abstract][Full Text] [Related]
17. Influence of immunoadsorption on the removal of immunoglobulin G autoantibodies in crescentic glomerulonephritis.
Esnault VL; Testa A; Jayne DR; Soulillou JP; Guenel J
Nephron; 1993; 65(2):180-4. PubMed ID: 8247177
[TBL] [Abstract][Full Text] [Related]
18. Immune reactive proteins in renal cell carcinoma patients treated by IFN alpha alone or in combination with vinblastine.
Juranić Z; Stanojević-Bakić N; Maletić V; Borkovacki R
Neoplasma; 1994; 41(4):229-32. PubMed ID: 7935998
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal immunoadsorption of xenoreactive natural antibodies in the pig/rhesus model: comparison of three methods.
Meyer C; Azimzadeh A; Beller JP; Kieny R; Lucchiari N; Ducros X; Boudjema K; Jaeck D; Cinqualbre J; Wolf P
Transplant Proc; 1996 Apr; 28(2):799-800. PubMed ID: 8623406
[No Abstract] [Full Text] [Related]
20. Model of removal of immunoglobulins from plasma by extracorporeal immunoadsorption with sepharose-protein A.
Davies PA
Int J Artif Organs; 1990 Dec; 13(12):837-45. PubMed ID: 2289837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
